Forskellige analyser antydede, at risikoen for disse følgevirkninger var mellem 1, 5 og 3, 2 gange større for paroxetin end for placebo.
Various analyses suggested that the risk of these outcomes was between 1.5 and 3.2 times greater with paroxetine compared to placebo.